Bank of Montreal’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
MWM
GAM
FFASIA
SIAP
SOS
NAM
Bank of Montreal's SBIO Position: Q2 2026 in Review
Bank of Montreal held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q2 2026 at 100 shares worth $6.46K. The position accounts for ﹤0.01% of the portfolio, ranked #3708.
Bank of Montreal first reported a position in SBIO in Q3 2019 and has held it in 15 quarters since. The position peaked at $15K in Q1 2020. 53 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.
- Bank of Montreal held 100 shares of ALPS Medical Breakthroughs ETF worth $6.46K as of Q2 2026.
- Bank of Montreal left its ALPS Medical Breakthroughs ETF share count unchanged in Q2 2026.
- ALPS Medical Breakthroughs ETF made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #3708 holding.
- Bank of Montreal first reported a position in ALPS Medical Breakthroughs ETF in Q3 2019 and has held it in 15 quarters since.
- Bank of Montreal's ALPS Medical Breakthroughs ETF position peaked at $15K in Q1 2020.
- 53 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.